Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6296589rdf:typepubmed:Citationlld:pubmed
pubmed-article:6296589lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:6296589lifeskim:mentionsumls-concept:C0016375lld:lifeskim
pubmed-article:6296589lifeskim:mentionsumls-concept:C1704410lld:lifeskim
pubmed-article:6296589lifeskim:mentionsumls-concept:C0750540lld:lifeskim
pubmed-article:6296589lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:6296589pubmed:issue3lld:pubmed
pubmed-article:6296589pubmed:dateCreated1983-3-24lld:pubmed
pubmed-article:6296589pubmed:abstractTextRats were given a flurazepam solution as their only water source for 4 weeks. The drug concentration was adjusted so the rats would consume 100-150 mg/kg daily. This treatment is known to cause a reduction in the number of specific benzodiazepine binding sites (receptor down-regulation) and tolerance to the locomotor impairment caused by the injection of a large test dose of flurazepam. Both the tolerance and the receptor down-regulation disappear within 24 hours after the end of chronic treatment. After 4 weeks of flurazepam treatment, rats were tested for locomotor impairment and loss of the righting response caused by pentobarbital, ethanol or diazepam. There was a small tolerance to pentobarbital. This lasted at least 4 days, but had disappeared by 7 days. Rats also had a small tolerance to ethanol, which disappeared between 24 and 48 hours after the end of chronic flurazepam treatment. In contrast, there was a large tolerance to diazepam, but this was gone by 24 hours after the end of chronic treatment. It appears that two types of tolerance develop during benzodiazepine treatment: (1) tolerance specific for benzodiazepines possibly mediated by receptor down-regulation, and (2) nonspecific tolerance, possibly analogous to that which develops during chronic barbiturate treatment.lld:pubmed
pubmed-article:6296589pubmed:languageenglld:pubmed
pubmed-article:6296589pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6296589pubmed:citationSubsetIMlld:pubmed
pubmed-article:6296589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6296589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6296589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6296589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6296589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6296589pubmed:statusMEDLINElld:pubmed
pubmed-article:6296589pubmed:monthJanlld:pubmed
pubmed-article:6296589pubmed:issn0024-3205lld:pubmed
pubmed-article:6296589pubmed:authorpubmed-author:SmithSSlld:pubmed
pubmed-article:6296589pubmed:authorpubmed-author:ChiuT HTHlld:pubmed
pubmed-article:6296589pubmed:authorpubmed-author:RosenbergH...lld:pubmed
pubmed-article:6296589pubmed:issnTypePrintlld:pubmed
pubmed-article:6296589pubmed:day17lld:pubmed
pubmed-article:6296589pubmed:volume32lld:pubmed
pubmed-article:6296589pubmed:ownerNLMlld:pubmed
pubmed-article:6296589pubmed:authorsCompleteYlld:pubmed
pubmed-article:6296589pubmed:pagination279-85lld:pubmed
pubmed-article:6296589pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6296589pubmed:meshHeadingpubmed-meshheading:6296589-...lld:pubmed
pubmed-article:6296589pubmed:meshHeadingpubmed-meshheading:6296589-...lld:pubmed
pubmed-article:6296589pubmed:meshHeadingpubmed-meshheading:6296589-...lld:pubmed
pubmed-article:6296589pubmed:meshHeadingpubmed-meshheading:6296589-...lld:pubmed
pubmed-article:6296589pubmed:meshHeadingpubmed-meshheading:6296589-...lld:pubmed
pubmed-article:6296589pubmed:meshHeadingpubmed-meshheading:6296589-...lld:pubmed
pubmed-article:6296589pubmed:meshHeadingpubmed-meshheading:6296589-...lld:pubmed
pubmed-article:6296589pubmed:meshHeadingpubmed-meshheading:6296589-...lld:pubmed
pubmed-article:6296589pubmed:meshHeadingpubmed-meshheading:6296589-...lld:pubmed
pubmed-article:6296589pubmed:meshHeadingpubmed-meshheading:6296589-...lld:pubmed
pubmed-article:6296589pubmed:year1983lld:pubmed
pubmed-article:6296589pubmed:articleTitleBenzodiazepine--specific and nonspecific tolerance following chronic flurazepam treatment.lld:pubmed
pubmed-article:6296589pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6296589pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:6296589pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed